Pure Global

Copal® G+C High Viscosity Radiopaque Bone Cement Containing Gentamicin And Clindamycin - FDA Registration MDR-05702

Access comprehensive regulatory information for Copal® G+C High Viscosity Radiopaque Bone Cement Containing Gentamicin And Clindamycin in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number MDR-05702 and manufactured by Heraeus Medical GmbH Philipp-Reis-Strasse 8/13, 61273 Wehrheim, Germany in Germany. The device was registered on January 25, 2024.

This page provides complete registration details including manufacturer information, importer/distributor details (Westech Meditrade, Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.

Free Database
Powered by Pure Global AI
FDA Official Data
Germany
MDR-05702
Copal® G+C High Viscosity Radiopaque Bone Cement Containing Gentamicin And Clindamycin
Registered medical device in Philippines
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Information
Product Name
Copal® G+C High Viscosity Radiopaque Bone Cement Containing Gentamicin And Clindamycin
Registration Number
MDR-05702
Manufacturer Details
Importer & Distribution
Importer/Distributor
Westech Meditrade, Inc.
Registration Dates
Issuance Date
January 25, 2024
Expiry Date
July 04, 2028